Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
The American Journal of Pathology
|
February 27, 2013
Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells
Saritha Chakilam, Muktheshwar Gandesiri, Tilman T Rau, et al.
Nature Medicine
|
February 25, 2014
In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease
Raja Atreya, Helmut Neumann, Clemens Neufert, et al.
EMBO Molecular Medicine
|
May 30, 2025
IL-36 signaling as a drug target in Crohn's disease patients with IL36RN mutations
Julia Hecker, Christina Plattner, Camila A Cancino, et al.
Gastroenterology
|
July 15, 2019
Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice
Rocío López-Posadas, Petra Fastancz, Luz Del Carmen Martínez-Sánchez, et al.
Journal of Crohn'S & Colitis
|
September 25, 2023
NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases
Simone Weber, Selina Sitte, Anna-Lena Voegele, et al.
Gut
|
December 4, 2021
Neutrophils prevent rectal bleeding in ulcerative colitis by peptidyl-arginine deiminase-4-dependent immunothrombosis
Moritz Leppkes, Aylin Lindemann, Stefanie Gößwein, et al.
Nature Cell Biology
|
July 9, 2021
E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis
Jay V Patankar, Tanja M Müller, Srinivas Kantham, et al.
Gastroenterology
|
November 20, 2018
Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation
Kristina Scheibe, Christina Kersten, Anabel Schmied, et al.
Gut
|
November 6, 2019
STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis
Christina Heichler, Kristina Scheibe, Anabel Schmied, et al.
International Journal of Cancer
|
April 25, 2025
Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?
Christoph Schubart, Lars Tögel, Maria Giulia Carta, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
The American Journal of Pathology
|
February 27, 2013
Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells
Saritha Chakilam, Muktheshwar Gandesiri, Tilman T Rau, et al.
Nature Medicine
|
February 25, 2014
In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease
Raja Atreya, Helmut Neumann, Clemens Neufert, et al.
EMBO Molecular Medicine
|
May 30, 2025
IL-36 signaling as a drug target in Crohn's disease patients with IL36RN mutations
Julia Hecker, Christina Plattner, Camila A Cancino, et al.
Gastroenterology
|
July 15, 2019
Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice
Rocío López-Posadas, Petra Fastancz, Luz Del Carmen Martínez-Sánchez, et al.
Journal of Crohn'S & Colitis
|
September 25, 2023
NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases
Simone Weber, Selina Sitte, Anna-Lena Voegele, et al.
Gut
|
December 4, 2021
Neutrophils prevent rectal bleeding in ulcerative colitis by peptidyl-arginine deiminase-4-dependent immunothrombosis
Moritz Leppkes, Aylin Lindemann, Stefanie Gößwein, et al.
Nature Cell Biology
|
July 9, 2021
E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis
Jay V Patankar, Tanja M Müller, Srinivas Kantham, et al.
Gastroenterology
|
November 20, 2018
Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation
Kristina Scheibe, Christina Kersten, Anabel Schmied, et al.
Gut
|
November 6, 2019
STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis
Christina Heichler, Kristina Scheibe, Anabel Schmied, et al.
International Journal of Cancer
|
April 25, 2025
Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?
Christoph Schubart, Lars Tögel, Maria Giulia Carta, et al.
Page
of 8